🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the immune response and the safety of a primary series schedule...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-01
Trial ID
NCT01839188
Treatments Being Tested
This is a multicenter, randomized, double-blinded, positive controlled stud...
Status
Completed
Location
Husada Utama Hospital
Start Date
2024-03-20
Trial ID
NCT06131554
This is a multicenter, randomized, observer-blinded, controlled, immune equ...
Status
Completed
Location
Lingga Health Research Center
Start Date
2020-02-04
Trial ID
NCT04204096
Treatments Being Tested
Infants aged 9 months will be randomized to receive a meningococcal vaccine...
Status
Completed
Location
Centre pour le Developpement des Vaccins du Mali
Start Date
2022-03-24
Trial ID
NCT05093829
Treatments Being Tested
This study was designed to evaluate the antibody response to a Menactra® bo...
Status
Completed
Location
Multiple Locations
Start Date
2004-02
Trial ID
NCT00777790
This study will be conducted among children in Saudi Arabia who previously ...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT00539032
The study investigated safety profile and the antibody responses to an expe...
Status
Completed
Location
Multiple Locations
Start Date
2003-08
Trial ID
NCT00771849
The purpose of this study is to describe the safety and immunogenicity of M...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-20
Trial ID
NCT07710872
This is a study to assess the safety, tolerability, and immunogenicity of V...
Status
Completed
Location
Multiple Locations
Start Date
2011-04-19
Trial ID
NCT01337167
Treatments Being Tested
The purpose of the study was to evaluate the immunogenicity and describe th...
Status
Completed
Location
Investigational Site
Start Date
2017-02-17
Trial ID
NCT03077438